Press Releases

May 07, 2024
SIGA Reports Financial Results for Three Months Ended March 31, 2024
Generated Product Sales of $24 Million and Pre-tax Operating Income of $11 Million Corporate Update Conference Call Today at 4:30 PM ET NEW YORK , May 07, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today reported financial
Mar 25, 2024
SIGA Names Larry Miller General Counsel
NEW YORK , March 25, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on health security and infectious diseases, announced the appointment of Larry Miller as general counsel, effective today.
Mar 12, 2024
SIGA Declares Special Cash Dividend of $0.60 Per Share
Represents a $0.15 Per Share Increase Over 2023 Special Dividend NEW YORK , March 12, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that its board of directors declared a special cash dividend of $0.60 per share on